Motor network gamma oscillations in chronic home recordings predict dyskinesia in Parkinson’s disease

• Published in: Brain (London, England : 1878) Vol. 147; no. 6; pp. 2038 - 2052
• Main Authors: Olaru, Maria, Cernera, Stephanie, Hahn, Amelia, Wozny, Thomas A, Anso, Juan, de Hemptinne, Coralie, Little, Simon, Neumann, Wolf-Julian, Abbasi-Asl, Reza, Starr, Philip A
• Format: Journal Article
• Language: English
• Published: UK Oxford University Press 03.06.2024
• Subjects: Adult; Aged; Deep Brain Stimulation - methods; Dyskinesias - etiology; Dyskinesias - physiopathology; Editor's Choice; Female; Gamma Rhythm - physiology; Humans; Male; Middle Aged; Motor Cortex - physiopathology; Nerve Net - physiopathology; Original; Parkinson Disease - physiopathology; Subthalamic Nucleus - physiopathology; neurological movement disorders; physiopathology; physiological biomarkers; wearable electronic devices; wireless technology; deep brain stimulation
• DOI: 10.1093/brain/awae004
• ISSN: 0006-8950; 1460-2156

Abstract In Parkinson’s disease, imbalances between ‘antikinetic’ and ‘prokinetic’ patterns of neuronal oscillatory activity are related to motor dysfunction. Invasive brain recordings from the motor network have suggested that medical or surgical therapy can promote a prokinetic state by inducing narrowband gamma rhythms (65–90 Hz). Excessive narrowband gamma in the motor cortex promotes dyskinesia in rodent models, but the relationship between narrowband gamma and dyskinesia in humans has not been well established. To assess this relationship, we used a sensing-enabled deep brain stimulator system, attached to both motor cortex and basal ganglia (subthalamic or pallidal) leads, paired with wearable devices that continuously tracked motor signs in the contralateral upper limbs. We recorded 984 h of multisite field potentials in 30 hemispheres of 16 subjects with Parkinson’s disease (2/16 female, mean age 57 ± 12 years) while at home on usual antiparkinsonian medications. Recordings were done 2–4 weeks after implantation, prior to starting therapeutic stimulation. Narrowband gamma was detected in the precentral gyrus, subthalamic nucleus or both structures on at least one side of 92% of subjects with a clinical history of dyskinesia. Narrowband gamma was not detected in the globus pallidus. Narrowband gamma spectral power in both structures co-fluctuated similarly with contralateral wearable dyskinesia scores (mean correlation coefficient of ρ = 0.48 with a range of 0.12–0.82 for cortex, ρ = 0.53 with a range of 0.5–0.77 for subthalamic nucleus). Stratification analysis showed the correlations were not driven by outlier values, and narrowband gamma could distinguish ‘on’ periods with dyskinesia from ‘on’ periods without dyskinesia. Time lag comparisons confirmed that gamma oscillations herald dyskinesia onset without a time lag in either structure when using 2-min epochs. A linear model incorporating the three oscillatory bands (beta, theta/alpha and narrowband gamma) increased the predictive power of dyskinesia for several subject hemispheres. We further identified spectrally distinct oscillations in the low gamma range (40–60 Hz) in three subjects, but the relationship of low gamma oscillations to dyskinesia was variable. Our findings support the hypothesis that excessive oscillatory activity at 65–90 Hz in the motor network tracks with dyskinesia similarly across both structures, without a detectable time lag. This rhythm may serve as a promising control signal for closed-loop deep brain stimulation using either cortical or subthalamic detection.Olaru et al. used neurostimulators with sensing capabilities to record over 900 h of motor cortex and basal ganglia activity from patients with Parkinson’s disease in their own homes, with wearable monitors providing scores of motor impairment. The results revealed a relationship between excessive gamma rhythms and dyskinesia.